NCT00387491

Dose Ranging Study in Healthy Methadone Maintenance Subjects

A Randomized, Double-blind, 4-period Crossover, Dose-ranging Study to Determine the Effects on the Oral-cecal Transit Time of Single Doses of MOA-728 and the Safety and Tolerability of Multiple Doses of MOA-728 in Stable Methadone Maintenance Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (planned)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Conditions

• Adult

Interventions

Type	Name	Description
DRUG	MOA-728

Timeline

• Start date: 2006-06-01
• Primary completion: 2006-10-01
• Completion: 2006-10-01
• First posted: 2006-10-13
• Last updated: 2019-11-25

Locations

1 site across 1 country: United States